I. Understanding Weimi
(A) Company Introduction
Guangzhou Weimi Biotechnology Co., Ltd. (hereinafter referred to as "Weimi Bio") was established in September 2013. The company is located on the third floor of Building D1, Liando U Valley, No. 29 Bishan Street, Huangpu District, Guangzhou. It is a high-tech enterprise committed to the integration and development of in vitro diagnostics (IVD) technology and industry, integrating research and development, production, and sales.
Weimi Bio has gathered a group of experts and technical talents in fields including biotechnology, genetics, microbiology, immunology, medical laboratory science, etc. With a team of doctoral, master's, technical, and management personnel, the company has established a modern enterprise operation model.
Weimi Bio possesses multiple core intellectual property rights and has mastered core technologies such as time-resolved fluorescence immunoassay, colloidal gold immunoassay, neuroimmunology technology, flow cytometry, enzyme-linked immunosorbent assay, and biochemistry. Its products cover diagnostic areas including cardiovascular and cerebrovascular diseases, inflammation, obstetrics and gynecology, cancer, diabetes, and kidney diseases.
Currently, Weimi Bio has obtained registration certificates from the National Medical Products Administration for over 200 products (including reagents and instruments). Most of these products have been used in more than 2,000 hospitals of various sizes across the country and have received positive feedback.
(B) Corporate Qualifications and Honors
In 2025, the platelet function detection reagent was certified as a Guangdong Province famous, high-quality, and new high-tech product.
In 2025, the company was successfully recognized as an innovative small and medium-sized enterprise.
In 2025, the company was successfully recognized as a specialized, refined, characteristic, and innovative small and medium-sized enterprise.
In 2025, the high-tech enterprise application was successfully recognized.
In 2024, the company obtained the first domestic Class II registration certificate for platelet activation detection reagents.
In 2024, the company obtained the first domestic Class II registration certificate for dedicated tubes for platelet detection.
In 2023, the company was recognized as a gazelle enterprise in Huangpu District.
In 2023, the company was recognized as a future unicorn enterprise in Guangzhou.
In 2023, the vascular endothelial growth factor (VEGF) assay kit (immunofluorescence chromatographic method) won the gold award for outstanding innovative products in China's in vitro diagnostics for 2022 at the "Chuangzhixing" Cup.
In 2023, the project "Construction of a College Student Innovation and Entrepreneurship Education Platform Based on In Vitro Diagnostics Product Development" undertaken by the company and commissioned by the Guangzhou Municipal Education Bureau successfully passed acceptance.
In November 2022, at the 19th CACLP (China Association of Clinical Laboratory Products and In Vitro Diagnostics) expo held in Nanchang, the company's flow cytometry platelet function detection kit, AI-based automatic detection for neuroimmune diseases, and multiple cytokine detection kits using flow cytometry and luminescent platforms won the gold award for China's excellent innovative products in in vitro diagnostics for 2021 at the "Chuangzhixing" Cup.
In November 2022, the company was selected as one of Guangzhou's 2022 future unicorn innovative enterprises.
In November 2022, the company was recognized as an innovative small and medium-sized enterprise in Guangdong Province.
In 2022, the company won the title of "Guangdong Province 2021 Quality Credit Class A Medical Device Manufacturer".
In 2022, the company was selected as one of Guangzhou's top 100 high-tech enterprises to be listed.
In 2022, the company was recognized as a gazelle enterprise of Guangzhou Development District for 2021.
In 2022, Weimi Bio was awarded the Five-Star Brand Certification.
In 2021, the company won the title of "Future Medical Top 100".
In 2021, the Guangzhou University of Chinese Medicine-Weimi Bio teaching base was established.
(C) Corporate Growth and Development Prospects
The company adopts innovative product development concepts, scientific management systems, and a high-quality and stable technical team to continuously expand channels and improve product competitiveness. It plans to rank among the top in the national industry in product development and sales within the next five years, developing into a medium-to-large medical enterprise and initiating an IPO plan. Currently, the company completed Series A financing in 2018, Series A+ financing in 2019, and Series B financing in 2021.
(D) Corporate Culture
Corporate Mission: Make testing more accurate, faster, and more convenient!
Corporate Vision: Become a great global IVD enterprise!
Core Values: Dedication, Integration, Service, Efficiency, and Quality!
II. Working at Weimi
(A) Work Environment
The company headquarters is located at Liando U Valley, No. 29 Bishan Street, Huangpu District, Guangzhou, with complete surrounding facilities and a beautiful environment. The park provides dedicated shuttle buses for commuting. The interior design is simple, clean, and bright.
(B) Work Atmosphere
The company team is young and energetic, advocating a people-oriented approach, promoting mutual assistance and cooperation, equality, openness, and unity. Workplace politics is strictly prohibited.
III. What We Offer
(A) Benefits and Compensation
[Comprehensive Salary]: Competitive remuneration.
[Performance Bonus]: Distributed based on company policy, job nature, and individual work performance.
[Year-end Bonus]: Determined based on annual performance evaluation results and company profitability.
(B) Welfare System
[Working Hours]: Monday to Friday, 8:30-17:30, 7.5 hours per day, weekends off (sales staff, technical staff, and special positions adopt flexible working hours).
[Social Insurance and Housing Fund]: Enrolled upon joining, providing you with peace of mind.
[Paid Leave]: Statutory paid annual leave and national public holidays, including annual leave (5 days after one year of service), sick leave, marriage leave, maternity leave, prenatal check-up leave, paternity leave, nursing leave, bereavement leave, and personal leave.
[Annual Leave]: For service years 1-4, 5 days; 5-9 years, 10 days; over 10 years, 15 days.
[Sick Leave]: For service years 1-3, 60% of original salary; 4-10 years, 70%; over 10 years, 80%.
[Prenatal Check-up Leave]: Pregnant employees can enjoy leave upon presenting prenatal check-up documents.
[Nursing Leave]: For nursing mothers, twice a day, 30 minutes each time, or a total of one hour per day can be used to arrive later or leave earlier.
[Bereavement Leave]: Three days for the death of direct family members (parents, children, spouse, and spouse's parents); one day for the death of siblings, grandparents, and maternal grandparents.
[Park Canteen]: Rich variety of dishes for you to choose.
[Park Shuttle]: Provides shuttle service for commuting (to/from Dashadong Metro Station and Jitang Metro Station).
[Annual Physical Examination]: Free annual physical examination for regular employees.
[Employee Welfare]: Traditional festival gifts, New Year red envelopes, team building activity allowances.
What does Guangzhou Weimi Biotechnology Co., Ltd. require? Who is Weimi Bio hiring? Weimi Bio recruitment: 销售类占比最多占45.8%,其次是医疗卫生/美容保健类占34.5%. What education can get in at Weimi Bio? 大专占比最多占67.3%,其次是硕士占16.1%. High education required at Weimi Bio? 硕士占16.1%. Work experience required at Weimi Bio? 3-5年占比最多占42.3%,其次是不限占26.8%. Where are the job locations at Weimi Bio? 广州占比最多占20.8%,其次是济南占8.3%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows